Objective: We aim to explain the correlation among IL-18 gene polymorphism, its protein expression and LEDVT in the Chinese Han population.
| INTRODUCTION
Venous thromboembolism (VT), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a widely-recognized disorder with a high incidence rate of ~131.5/100 000 people every year. 1 DVT and PE are the two different stages of VT, which are associated with common risk factors caused by environmental, behavioral, and genetic interactions. 2, 3 DVT is the fundamental reason for cardiovascularrelated mortality and its treatment such as anticoagulation therapy and mechanical leg compression only has a function of palliation. 4 Systemic or oral anticoagulation therapy remains ineffective in eliminating thrombus burden and it cannot prevent the post-thrombotic syndrome as well. 5 Lower extremity deep vein thrombosis (LEDVT), is predominantly a disease of older age which is a now more prevalent in clinical studies and it typically starts below the knee, and yet may extend proximally, leading to PE. 6 It is a prevailing disease with an incidence rate of 1/1000 adults annually. 7 Acute DVT may result in PE, thrombus progression, phlegmasia cerulea dolens, venous gangrene, phlegmasia alba dolens, and even death. 8 The standard treatment for DVT is oral anticoagulation, aiming to restrict the thrombus propagation and reduce PE risk. 9 As a prevalent disorder, various genetic factors have been indicated to affect the susceptibility toward thrombosis as well as DVT incidence. 10 Interleukin-18 (IL-18), a member of the IL-1 superfamily, can en- 
| MATERIALS AND METHODS

| Ethics statement
All experiments in this study were approved by the Ethics Committee of Huzhou Central Hospital and all patients signed the informed consent. Hospital and were enrolled as control group, among which 79 were male and 71 were female with a mean age of (55.92 ± 13.22) years old and a mean weight of (68.4 ± 10.6) kg.
| Study subjects
| Clinical data collection
All the data, including the gender, age, body mass index (BMI), tri- 
| Evaluating the Serum IL-18 level
A total of 2 mL of peripheral venous blood was collected from all the subjects on an empty stomach, later it was put in an acid-citrate dextrose (ACD) anticoagulant tube (Shanghai Qian Ling Chemical Co., Ltd., Shanghai, China), for centrifugation (3000 r/min) for 5 minutes, along with the serum preserved at a temperature of −20°C in the refrigerator for further use. An enzyme-linked immunosorbent kit (ELISA, R&D System, Minneapolis, Minn., USA) was used to determine the serum IL-18 level.
| Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)
The PCR-RFLP was used to detect the polymorphism of IL-18 gene promoters −137G/C and −607C/A. The modified salting out method was used to extract the leukocyte DNA and based on the Primer 
| Statistical analysis
The SPSS 21.0 software (IBM Corp., Armonk, NY, USA) was used for the data analysis. The measured data was presented as mean ± standard deviation and the t-test was used to compare the data between the two groups. The data calculated was also demonstrated in percentages and ratios and the chi-square test was adapted for group comparisons. The Hardy-Weinberg equilibrium (HWE) test was performed to detect the group representation, genotype and allele frequency using the chi-square test and multivariate analysis of variance using binary logistic regression analysis. P < .05 meant there was a statistically significant difference.
| RESULTS
| Clinical data of the subjects in the LEDVT and control groups
According to the comparison the LEDVT group had increased levels of BMI, GLU, Fg, BUN, and ApoB but decreased APTT when compared to that in the control group (all P < .05). There were no significant difference in the gender, age, TG, LDL, HDL, CHOL, Cr, ALT, AST, and
ApoA 1 between the two groups (P > .05) ( Table 1 ).
| Identification of PCR restriction enzyme electrophoresis
As shown in the Figure 1 , the PCR restriction enzyme electrophore- 
T A B L E 1
The clinical data between the LEDVT and control groups
| Frequency distribution of IL-18 genotypes and its alleles in the LEDVT and control groups
The HWE demonstrated that both IL-18 −137G/C polymorphism and −607C/A polymorphism were in accordance with the HWE, which verified that all the selected data were of group representation.
The GC + CC genotype and C allele in −137G/C polymorphism significantly increased in the control group compared to those in the LEDVT group (all P < .05), suggesting that GC + CC geno- Table 2 ).
| Changes of serum IL-18 level in different genotypes of IL-18 −137G/C polymorphism and −607C/A polymorphism
As shown in Figure 2 , the IL-18 levels in the LEDVT and control groups were (268.74 ± 37.91) pg/mL and (165.28 ± 28.15) pg/mL, respectively, indicating that the serum IL-18 level increased significantly in the LEDVT group compared to the control group (P < .05). IL-18 level was high in the LEDVT group when compared to the control group with respect to the same genotype in −607C/A and −137G/C polymorphisms (P < .05), and within the LEDVT group, IL-18 level was higher in the GG genotype than that in the GC + CC genotype of −137G/C polymorphism (P < .05), while no such significant difference was found in the control group (P > .05). Hence, this experiment was not able to establish any association between genotypes of −607C/A polymorphism and serum IL-18 level in the LEDVT and control groups (P > .05) ( Table 3) .
| Multivariate logistic regression analysis for the risk factor of LEDVT
The different genotypes of −137G/C polymorphism and levels of IL-18, BMI, GLU, APTT, BUN, ApoB and Fg, were considered as the potential risk factors in multivariate logistic regression analysis of our study. The input method was used for the analysis and BUN, IL-18-GG polymorphism and IL-18 level were independent risk factors, but
APTT was a protective factor of LEDVT (all P < .05); whereas the BMI, GLU, ApoB, and Fg made no significant difference (P > .05) ( Table 4 ).
| DISCUSSION
LEDVT, along with its complications still has a high incidence among the hospitalized patients. 20 It is a multifactorial disease with acquired and genetic risk factors playing a significant role in its pathogenesis. [21] [22] [23] [24] Some genetic factors were mentioned in the etiology of LEDVT. 25, 26 Thus, in this study we aim to demonstrate the association of IL-18-GG polymorphism and IL-18 level with LEDVT. In the end, our study provided evidence that GG genotype of −137G/C polymorphism and IL-18 level were independent risk factors of LEDVT and IL-18 gene polymorphism can influence the serum IL-18 level in LEDVT patients.
Initially, the LEDVT group had increased levels of BMI, GLU, Fg, BUN, ApoB and IL-18 but decreased APTT when compared to the control group. BMI was demonstrated as a biomarker for improvement in proximal DVT disease. 27 GLU and FBG levels were also a main criterion used to diagnose the glucose intolerance. 28 Fg, being a multifunctional plasma protein, plays a crucial role in several biological processes. 29 A study examined the effect of Fg on intracranial hemorrhage and concluded that Fg concentrate was a suitable therapy for enhancing plasma Fg for the treatment of intracranial hemorrhage along with hematoma expansion. 30 The BUN, which 
(B) (A)
is a broadly available, easily determinable and inexpensive marker, could be adapted to confirm patients who are at the risk of cardiovascular endpoints, and the elevated BUN was inconsistency with increased mortality. 31, 32 The apoB to apoA1, an indicator to balance the atheroprotective and atherogenic cholesterol transport, 33 was found to be independently related to cardiovascular diseases.
34
IL-18-stimulated macrophages triggered endothelial cell apoptosis, indicating that, in vivo, excess IL-18 suppressed tumor blood vessel formation. 35 The APTT is widely used to monitor therapeutic anticoagulation with standard heparin. 36 Together, BUN, and IL-18 level were independent risk factors, but APTT was a protective factor of LEDVT, which was also further proved by the multivariate logistic regression analysis.
The IL-18 level elevated remarkably in the LEDVT group when compared to the control group with respect to the same genotype in −607C/A and −137G/C, and in the LEDVT group IL-18 level was higher in the GG genotype of −137G/C than that in the GC + CC genotype. A study also revealed that IL-18 gene −137G/C polymorphism as well as −137C/-607A haplotype is related to the colorectal cancer. 37 Another study indicated that IL-18 −137G/C and −607A/C polymorphisms could control the IL-18 protein levels and further proved in a study that GG genotype of the −137G/C polymorphism was 2.165-times more risky than the GC genotype for the prostate cancer progression and lowered the rate of progression-free survival. 16 Importantly, IL-18-607A/C and also −137G/C promoter polymorphisms were associated with susceptibility to penicillin al- the new diagnostic markers of DVT, and they both might provide the novel molecular target for accelerating thrombus resolution in patients with DVT. 45 All the data mentioned above was consistent with our findings, and we reached to the conclusion that LEDVT patients with GG genotype of the IL-18 −137G/C gene had elevated IL-18 level.
In conclusion, our study demonstrated that the GG genotype of IL-18 −137G/C polymorphism and IL-18 level are independent risk factors of LEDVT, and IL-18 gene polymorphism can influence the serum IL-18 level in LEDVT patients. However, due to the limited data and experimental conditions, more improvements in the study could be done in the future.
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